Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Blood
; 142(8): 700-710, 2023 08 24.
Article
in En
| MEDLINE
| ID: mdl-37319437
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Epstein-Barr Virus Infections
/
Graft vs Host Disease
Type of study:
Clinical_trials
/
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Blood
Year:
2023
Type:
Article
Affiliation country:
Morocco